文献速递乳房整形与再造显微修复重建

乳房深 inferior 腹壁穿支皮瓣再造术中低血压患者术中多巴胺输注的临床结局

Clinical outcomes of intraoperative dopamine infusion for hypotensive patients during breast reconstruction with deep inferior epigastric perforator (DIEP) flaps.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2022-06-22

单中心回顾性研究比较2018年10月至2020年3月间接受腹壁下深穿支皮瓣乳房再造术中输注多巴胺至少1小时(DA组25例)与未输注多巴胺(ND组43例)患者的结局。两组均无皮瓣相关并发症,DA组总静脉输液量更高(ND 3.81L vs DA 5.04L,p=0.005),但多巴胺启动后液体需求降低(ND 839 mL/h vs DA 479 mL/h,p=0.004)、尿量增加(ND 98.0 mL/h vs DA 340 mL/h,p<0.001)。作者认为多巴胺在微血管乳房再造中安全,可能对血流动力学不稳定患者有益。

要点

  • DA组与ND组均无皮瓣相关并发症。
  • DA组总静脉输液量高于ND组(3.81L vs 5.04L,p=0.005)。
  • 多巴胺启动后DA组液体需求降低、尿量增加。

核心结论

  • 多巴胺在微血管乳房再造中使用是安全的。
  • 多巴胺可能通过稳定血压和促进液体平衡接近中性而使血流动力学不稳定患者获益。

研究设计与样本

  • 单中心回顾性综述,纳入2018年10月至2020年3月间接受腹壁下深穿支皮瓣乳房再造的患者。
  • 比较接受至少1小时多巴胺(DA组25例)与未接受多巴胺(ND组43例)患者的基线特征、合并症、液体平衡、住院时间和不良结局。
  • 对双侧手术和接受多巴胺的患者进行亚组分析。

主要发现

  • 两组均无皮瓣相关并发症。
  • DA组总静脉输液量高于ND组(ND 3.81L vs DA 5.04L,p=0.005)。
  • 多巴胺启动后,DA组液体需求低于ND组(ND 839 mL/h vs DA 479 mL/h,p=0.004),尿量高于ND组(ND 98.0 mL/h vs DA 340 mL/h,p<0.001)。
  • DA组术中尿量(ND 1.37 L vs DA 3.48 L,p<0.001)和尿量速率(ND 1.9 ml/kg/h vs DA 3.7 ml/kg/h,p<0.001)均高于ND组。
  • 双侧手术患者中,DA组液体平衡较ND组更接近中性(ND +3.43 L vs DA +2.26 L,p=0.03)。

临床怎么用

  • 作者认为多巴胺在微血管乳房再造中使用是安全的,可能对血流动力学不稳定患者有益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dopamine has a favorable therapeutic profile but has not been widely used to treat hypotension during microvascular breast reconstruction. The purpose of this study was to evaluate outcomes in patients who received dopamine during breast reconstruction using deep inferior epigastric perforator (DIEP) free flaps and compare them with patients who did not receive dopamine. METHODS: A single-center retrospective review was performed for patients who underwent breast reconstruction with DIEP free flaps between October 2018 and March 2020. Patient demographics, comorbidities, fluid balance, hospital stay, and adverse outcomes were compared between patients who received at least 1 h of dopamine (DA) and patients who did not receive dopamine (ND). Subgroup analyses were performed for bilateral procedures and patients who received dopamine. RESULTS: Twenty-five patients in the DA group and 43 patients in the ND group met the inclusion criteria. There were no flap-related complications. Patients who had dopamine initiated to maintain blood pressures had a higher total volume of intravenous fluid (ND:3.81L vs. DA:5.04L, p = 0.005). However, DA patients exhibited decreased fluid requirements (ND:839 mL/h vs. DA:479 mL/h, p = 0.004) and increased urine output (ND:98.0 mL/h vs. DA:340 mL/h, p = <0.001) once dopamine was initiated. Intraoperative urine output (ND:1.37 L vs. DA:3.48 L, p < 0.001) and rate (ND:1.9 ml/kg/h vs. DA:3.7 ml/kg/h, p < 0.001) were increased in the DA group. The fluid balance of patients undergoing bilateral procedures was closer to neutral for patients who received dopamine (ND:+3.43 L vs. DA:+2.26 L, p = 0.03). CONCLUSION: Dopamine is safe to use in microvascular breast reconstruction. It may be beneficial for hemodynamically labile patients by stabilizing blood pressure and facilitating a neutral fluid balance.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Rhee DH, Constantine RS, Colakoglu S, et al. Clinical outcomes of intraoperative dopamine infusion for hypotensive patients during breast reconstruction with deep inferior epigastric perforator (DIEP) flaps. J Plast Reconstr Aesthet Surg. 2022. PMID: 35915016. doi:10.1016/j.bjps.2022.06.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。